Vimarsana
Biggest News Aggregation in the World

Page 2 - Magellan Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Magellan Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Magellan Diagnostics Today - Breaking & Trending Today

Medical device company to pay $42M to resolve lead-testing defect charges - Vimarsana News

Medical device company to pay $42M to resolve lead-testing defect charges

BOSTON — A medical device company headquartered in Billerica, Mass., has agreed to pay $42 million and plead guilty to resolve charges that it concealed a malfunction in its lead-testing

Medical Device Legal News - Vimarsana News

Medical Device Legal News

This weekly news program, hosted by partner Sam Bernstein, covers recent legal and compliance developments for medical device companies, including…

H|T: The Healthtech Times – Lululemon's failed attempt at becoming a tech company - Vimarsana News

H|T: The Healthtech Times – Lululemon's failed attempt at becoming a tech company

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.

Company execs knowingly sold flawed lead-testing devises - Vimarsana News

Company execs knowingly sold flawed lead-testing devises

(CHILDREN'S HEALTH DEFENSE) – Three former executives of a Massachusetts-based health diagnostics company deliberately concealed a problem with the company’s lead-testing devices that produced inaccurately low results for tens of thousands of children, according to federal prosecutors. Amy Winslow, Reba Daoust and Mohammad Hossein Maleknia — all former executives at Magellan Diagnostics — “deceived customers…

Source: wnd.com
Lead Paint Testing Firm Executives Accused of Marketing Faulty Devices - Vimarsana News

Lead Paint Testing Firm Executives Accused of Marketing Faulty Devices

Three former executives of a company that makes machines that test lead levels in humans deliberately concealed a problem with the devices that produced